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Why is a (political and) economic perspective is useful? 
1. Growing economic relevance of health (sector) 
Total health expenditure: 
• 10% of global GDP in 2014 
• US$Int 1272 per capita per year in 2014 
• Huge variations across countries: US$Int 93 LICs- 4609 HICs in 2014 
Income is the main determinant of health expenditure growth 
Why is a (political and) economic perspective is useful? 
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Why is a (political and) economic perspective is useful? 
1. Growing economic relevance of health (sector) 
Health sector both labor and brain intensive 
Investments in health sector have impact on quantity and quality of employment 
Why is a (political and) economic perspective is useful? 
The world's largest employers:  
1. US Department of Defense - 3.2 million  
2. People's Liberation Army (China) - 2.3 million  
3. Walmart - 2.1 million  
4. McDonald's - 1.9 million  
5. UK NHS - 1.7 million  
6. China National Petroleum Corporation - 1.6 million  
7. State Grid Corporation of China - 1.5 million  
8. Indian Railways - 1.4 million  
9. Indian Armed Forces - 1.3 million  
10. Hon Hai Precision Industry (Foxconn) - 1.2 million ends  
 
Why is a (political and) economic perspective is useful? 
1. Growing economic relevance of health (sector) 
Commercial/Business practices & interests have significant impact on health and 
health care delivery – e.g. 
• (Big) Tobacco 
• (Big) Food 
• (Big) Pharma 
Importance of global, national, and local regulation and governance 
 
Why is a (political and) economic perspective is useful? 
1. Growing economic relevance of health (sector) 
Commercial/Business practices & interests have significant impact on health 
and health care delivery 
Global Health Governance challenges-  
e.g. WHO Funding sources (budget 2014-15): 
-  Assessed contributions: 23.4% (929 M US$) 
-  Voluntary contributions: 76.6% (3049 M US$) 
Why is a (political and) economic perspective is useful? 
2. Paradigm shift: health from consequence to determinant 
of economic development 
 
Traditional economic thinking: income growth is a key factor for 
improved population health 
• Policies prescribed by international financial institutions for LICs focused on 
growth in GDP to the neglect and even the detriment of population health 
Health more relevant in global development policies 
Why is a (political and) economic perspective is useful? 
2. Paradigm shift: health from consequence to determinant 
of economic development 
 
Strong empirical evidence that relation health and development is bi-directional 
• WHO Commission on Macroeconomics and health (2000) 
Health more relevant in global development policies 
Growth in global health financing 

Why is a (political and) economic perspective is useful? 
2. Paradigm shift: health from consequence to determinant 
of economic development 
 
http://www.cddep.org/projects/lancet_commission_investing_health 
 
Millennium Development Goals  
   In 2000 Millennium Development Goals for 2015 
Why is a (political and) economic perspective is useful? 
2. Paradigm shift: health from consequence to determinant 
of economic development 
 
Unprecedented funding to global health – now 
over? 
 
 
http://vizhub.healthdata.org/fgh/ 
 
 
From: Sources and Focus of Health Development Assistance, 
1990–2014 
JAMA. 2015;313(23):2359-2368. doi:10.1001/jama.2015.5825 
Health in Sustainable Development Goals 
Health in Sustainable Development Goals 
Why is a (political and) economic perspective is useful? 
3. Relevance of social determinants of health 
 
The greatest share of health problems is attributable to the social conditions in 
which people live and work that are key determinants of health 
Health inequalities are caused by inequitable distribution of more fundamental social, 
political and economic forces 
Why is a (political and) economic perspective is useful? 
3. Relevance of social determinants of health 
 
Health depends on many factors and policies that are outside of the remit of health 
ministries  
Action needed 
• to improve basic living conditions -health services, education, and working conditions;  
• to reduce inequalities in power and resources;  
• to create transparency by monitoring and measuring inequalities in health. 
Why is a (political and) economic perspective is useful? 
4. Inequalities  - equity in health and access to care 
 
Despite dramatic improvements in average population health, disparities 
between the poorest and least poor have been increasing: 
• in economic burden of ill health;  
• in access to health care; and  
• in health outcomes  
Health systems are ill equipped to identify and respond to health 
inequities, and often cause greater inequity  
Why is a (political and) economic perspective is useful? 
4. Inequalities in health  
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Why is a (political and) economic perspective is useful? 
4. Inequalities  in health and access to care 
 
Examples: 
 
Maternal mortality: 
- http://apps.who.int/gho/data/node.sdg.3-1-viz?lang=en 
 
NCDs - Mortality rate attributed to cardiovascular disease (CVD), 
cancer, diabetes or chronic respiratory disease (CRD) 
- http://apps.who.int/gho/data/node.sdg.3-4-viz-1?lang=en 
 
UHC indicators: 
-  http://apps.who.int/gho/cabinet/uhc.jsp 
 
 
Why is a (political and) economic perspective is useful? 
4. Inequalities  in access to care 
 Inequality in reproductive, maternal, newborn and child health (RMNCH) 
interventions 
Composite coverage index: weighted score reflecting cover age of eight reproductive, maternal, newborn and 
child health interventions along the continuum of care 
Why is a (political and) economic perspective is useful? 
4. Inequalities  in health and access to care 
 
Wealthy groups often benefit more than the poor from government spending 
Private sector weakly governed/regulated - the poorest often receive the poorest 
quality of care within the private sector  
A health system perspective 
 Health outcomes mediated by complex interactions between diseases, 
environment, and socio-economic systems at micro and macro levels  
 
 The “black box misconception”:  “we must simply get technologies and 
other inputs in place and then outputs will somehow walk their way” 
(Frank J., PLoS Med, 2010) 
A health system perspective 
 
 
Affordable 
• Public health 
• High value 
interventions 
• Low OOPs 
 
Adaptable 
• Respond to changes 
in BoD, Social & 
cultural, Tech etc. 
Acceptable 
• Stakeholders 
involvement 
• Patient Involvement 
• Trust  
Characteristics of a sustainable Health System 
Health system complexity 
 
 
 
 
 
“A system is not the sum of its parts; It is 
the product of the interaction of its parts” 
 
 
 
 
What happens between the sub-systems is 
more important than what goes on within 
them; and is usually neglected”. 
 
 
Source: de Savigny and Adam (2009) 
A framework of connected sub-systems 
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Health systems are 
complex adaptive 
systems 
Medicines & Technologies sub-system – 
Tanzania 2007 
All building blocks 
are fragmented 
Health system complexity 
Medicines & Technologies sub-system – Tanzania 2007 
A health system (and economic) perspective 
Three sets of health challenges: 
1. The huge health challenges still suffered by vulnerable groups in 
low and middle income countries 
2. The shift in the disease burden towards non communicable 
diseases 
3. The burden of medical expenditure on households and societies 
 
 
 
  
 
Challenge 1: The huge health challenges of vulnerable 
groups in low and middle income countries 
 
 
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 
188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015 Aug 27. 
Challenge 1: The huge health challenges of vulnerable 
groups in low and middle income countries 
 
 
Scaling up Effective Coverage of  available preventive and curative 
interventions would dramatically reduce this burden 
Most of the BoD suffered by vulnerable groups is for communicable 
diseases, neonatal, maternal, nutritional conditions – that can be 
prevented or treated with “available” interventions relatively inexpensive 
Example: Effective coverage of malaria case management 
 
A few studies estimated low effective coverage of malaria case management 
in malaria endemic areas in Africa (e.g. INESS http://indepth-
network.org/projects/iness) 
 
Source: INESS http://indepth-network.org/projects/iness 
 
Example: Effective coverage of malaria case management 
 
Effective Coverage (E) and Access to Any Provider (A) by 
Country (%). 
 
About half of the potential gain from 
treatment is lost to inefficiencies 
Effective coverage and malaria service indicators 
E
A
Pf
Dact
H
T
25
50
75
100
BFA
E
A
Pf
Dact
H
T
25
50
75
100
COD
E
A
Pf
Dact
H
T
25
50
75
100
ETH
E
A
Pf
Dact
H
T
25
50
75
100
KEN
E
A
Pf
Dact
H
T
25
50
75
100
NGA
E
A
Pf
Dact
H
T
25
50
75
100
UGA
We used Demographic Health Surveys and published sources to estimated effective coverage 
of Malaria Case Management in 43 high burden African Countries 
Galactionova K, Tediosi F, et al (2015) Effective Coverage and Systems Effectiveness for Malaria Case Management in Sub-
Saharan African Countries. PLoS 10(5): e0127818. doi:10.1371/ 
 
E A 
Galactionova K, Tediosi F, de Savigny D, Smith T, Tanner M (2015). Effective Coverage and Systems Effectiveness 
for  Malaria Case Management in Sub-Saharan African Countries. PLoS ONE 10(5): e0127818. 
doi:10.1371/journal.pone.0127818 
Effective coverage (E) and Access to malaria treatments (A) 
 
Effective coverage of malaria case management: Nigeria 
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Access to treatment 
Access to formal care 
Compliance with first-line treatment 
Adherence with drug 
regimen 
Drug cure rate 
Effective coverage 
Bottlenecks in service provision: each country has different challenges 
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Galactionova K, Tediosi F et al. PLoS ONE 10(5): e0127818. doi:10.1371/journal.pone.0127818 
Example: Impact of strategies to control and eliminate 
Neglected Tropical Diseases 
 
 
 Neglected Tropical Diseases affect vulnerable people mainly in marginalized areas of low 
and middle income countries   
 Many of them could be prevented or treated with relatively simple interventions – e.g. 
preventive chemotherapy 
WHO-WB Tracking universal health coverage: first global monitoring report 
http://www.who.int/healthinfo/universal_health_coverage/report/2015/en 
Example: Impacts of strategies to control and eliminate 
Neglected Tropical Diseases 
Lymphatic Filariasis 
 Chronic forms of morbidity: hydrocele and lymphoedema  
 Global program to eliminate LF with  Mass Drug Adminisstration (MDA) 
of DEC + albendazole or ivermectin+ albendazole covering at least 
65% of the at-risk population for at least 5 years 
 A key challenge for the elimination of LF is the expansion of 
geographic coverage of MDA programmes 
 Prior studies have not considered long terms health benefits, costs, and 
cost-effectiveness associated with scaling-up geographic coverage 
 
 
Example: Impacts of strategies to control and eliminate 
Neglected Tropical Diseases 
Lymphatic Filariasis 
LF prevalent in poor populations in several countries (2.77 million DALYs) 
 
 
Scenarios compared for elimination and eradication of 
Lymphatic Filariasis 
Kastner RJ, Tediosi F  et al (2015) What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of 
Scaling Up Mass Drug Administration Programs. PLoS Negl Trop Dis 9(10) 
Key features of the proposed scenarios for elimination and eradication of LF 
Maps of the final year of MDA per country  
Kastner RJ, Tediosi F  et al (2015) What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling 
Up Mass Drug Administration Programs. PLoS Negl Trop Dis 9(10) 
Cumulative number of treatments by year 
Impacts of LF elimination and eradication strategies 
If MDA drastically scaled up and 
expanded, the final round of MDA 
for LF eradication could be 
delivered by 2028 
 
Impacts of LF elimination and eradication strategies 
 
Cumulative N of DALYs averted  
Stone CM,  Tediosi F et al. Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying 
levels of mass drug administration scale-up and geographic coverage. BMJ Global Health 2016;1 
Incremental cost-effectiveness plane and 95% 
CI ellipses 
 Scaling up coverage of MDA faster will accumulate more benefits 
and savings 
 Health and “economic” support for increasing the intensity of MDA 
programmes 
Challenge 2: Shift in the disease burden towards non 
communicable diseases 
 
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy 
(HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015 Aug 27. 
Challenge 2: Shift in the disease burden towards non 
communicable diseases 
 
Example: Ghana burden of disease profile 
http://www.healthdata.org/ghana 
 
Ghana.pptx 
Challenge 2: Shift in the disease burden towards non 
communicable diseases 
 
 
 High social burden – prolonged disability, less resources 
within families, reduced productivity 
 More complex ways to deliver services – e.g. coordination of 
care, integration of different levels of care, integration of 
health and social care  
 The “medical-industrial complex” response to NCDs is 
expensive 
 
NCDs WHO Global Health Observatory 
 
 
 Policy: Existence of operational policy/strategy/action plan for cardiovascular 
diseases  
http://gamapserver.who.int/gho/interactive_charts/ncd/health_systems/policy/atlas.html 
 
 Surveillance: Existence of an NCD surveillance and monitoring system in place to 
enable reporting against the nine global NCD targets  
http://gamapserver.who.int/gho/interactive_charts/ncd/health_systems/surveillance/atlas.html 
Medical technologies is a driver of health expenditure 
 
 
 
 
 
 
 
 
 
Soresen et at.  ClinicoEconomics and Outcomes Research 2013:5 223–234 
Innovation in health care does not necessarily lead to 
increase in productivity as in other sectors 
Key to sustainability: «governing» use of medical 
technologies to improve population health 
Physical resources for health  in OECD countries 
Computed tomography (CT) scanners - / In hospitals / In ambulatory care providers 
Per 1,000,000 inhabitants, 2013 
Source: OECD Health care resources 
Physical resources for health  in OECD countries 
Magnetic resonance imaging (MRI) units. Total / In hospitals / In ambulatory care 
providers, Per 1 000 000 inhabitants, 2013  
Source: OECD Health care resources 
Example: Differences in All‐Cause Mortality and Length of 
Stay for Patients with Hip Fracture 
 Administrative datasets (registers) of use of services and medicines linked 
at indivdual level with mortality registers  
 All‐Cause Mortality and Length of Stay for Patients with Hip Fracture 
and association of them with selected country and regional level 
factors 
 
 
 
Medin E, Tediosi F  et al. 2015. European regional differences in all-cause mortality and 
length of stay for hip fracture patients. Health Economics 24 (Suppl. 1): 53-64.  
 Assessment of outcomes, use of services and costs for Hip fracture in 7 
countries: Finland, Hungary, Italy, the Netherlands, Norway, Scotland, 
and Sweden 
 
  
 
 
 
 
a: National and regional 
variation in 30‐day and 
one‐year mortality rate (%), 
age and sex‐standardised 
mortality rates 
b: National and regional 
variation in length of first 
hospital episode and 
during one‐year (days), 
age‐and sex‐standardised 
rates 
Medin E, Tediosi F  et al. 2015. European regional differences in all-cause mortality and length of stay for hip fracture 
patients. Health Economics 24 (Suppl. 1): 53-64.  
Example: European Regional Differences in All‐Cause 
Mortality and Length of Stay for Patients with Hip Fracture 
Example: European Regional Differences in All‐Cause 
Mortality and Length of Stay for Patients with Hip Fracture 
 Remarkable variations in mortality and LoS, across countries and within 
countries 
 Regression models showed variation in mortality & LoS weakly associated 
only with some country-level factors -e.g. clinical guidelines  
 Variation probably due to broader health systems and societal factors 
- e.g. role of homecare, how societies deal with care of elderly people, 
etc. 
 
 
 
 
 
 
 
 
The “medical-industrial complex” response to NCDs 
Seeking sickness in contemporary health systems 
 New diagnostic technologies continuously developed 
 Culture that more diagnosis=more treatment=better health 
 
“In the past, people sought health care because they were sick. Now the 
medical-industrial complex seeks patients. It encourages those with 
minor symptoms to be evaluated and urges those who feel well to get 
“checked” — just to make sure nothing is wrong” (H. Gilbert Welch, 2009) 
 
 
 
 
Paradigm of Early Diagnosis 
The “medical-industrial complex” response to NCDs 
Opportunities to prevent symptomatic disease in some people, at the cost of 
maximizing the diagnosis in others who are not destined ever to develop 
symptoms or die 
 
 
 
 
 
November 16, 2017 54 
Occurs when people without symptoms are diagnosed with 
a disease that ultimately will not cause them to experience 
symptoms or early death (Welch G, et al, 2011.) 
Overdiagnosis 
Pathways to overdiagnosis 
Expanding disease definitions – new categories, lowering 
thresholds, changing diagnostic methods 
    Examples of changes disease definitions 
November 16, 2017 55 
H. Gilbert Welch et al (2012). Overdiagnosed: Making People Sick in the Pursuit of Health 
Old definition New definition
Change in threshold
Diabetes
Fasting sugar 140 to 126 11'697'000        13'378'000      1'681'000     14%
Hypertesion
Systolic BP 160 to 140
Diastolic BP 100 to 90
Hyperlipidemia
Total cholesterol 240 to 200 49'480'000        92'127'000      42'647'000  86%
Osteoporosis
T score -2.5 to -2.0 8'010'000          14'791'000      6'781'000     85%
35%
New cases Increase (%)Condition
38'690'000        52'180'000      13'490'000  
Disease prevalence
Balancing benefits and harms of overdiagnosis 
Example: Chance benefit of cholesterol medicines for near 
normal cholesterol 
If 100 patients are diagnosed with near normal cholesterol and 
treated for a lifetime, how many will be: 
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Winners: Tratment saved them from first major heart event 8 
Treated for Naught: Had first major heart events despite 
treatment 
14 
Losers: Overdiagnosed – treatment couldn’t help them 
because they were never going to have heart events  
78 
H. Gilbert Welch et al (2012). Overdiagnosed: Making People Sick in the Pursuit of Health 
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Example of overdiagnosis – Breast cancer 
 
 
 
 
 
 
For every 2000 women (50 years old) invited for 
mammography screening throughout 10 years 
 
Benefits: 
• 1 women will avoid dying of breast cancer 
Harms: 
• 10 healthy women will be treated unnecessarily 
• More than 200 women will experience psychological distress for years 
because of false positive findings 
Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2013 
Jun 4; 
Pathways to overdiagnosis 
Overdiagnosis made incidentally—“incidentalomas” 
 In 1000 people with no symptoms who elected to undergo total-
body CT screening: 
 86% had at least one abnormality detected 
 The average individual had 2.8 abnormalities  
(Frtado CT et al. Radiology 237 (2005):385-94) 
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Challenge 3: Burden of medical expenditure on households 
and societies 
 
1. Micro- households level: Impoverishing effects of medical  
expenditures: 
 Every year 100 million are pushed into poverty and 150 million people suffer 
financial catastrophe because of out-of-pocket expenditure on health services - 
Xu K, Evans DB, et al (2007) 
 About a quarter of households in low income and middle-income 
countries borrow money or sell items to pay for health care  - Kruk ME et 
al (2009) 
2. Macro level: Global Health Expenditure 10% of global GDP – huge 
differences across countries unrelated to burden of disease 
Burden of medical expenditure on households and societies 
Burden of medical expenditure on households and societies 
Burden of medical expenditure on households and societies 
Burden of medical expenditure on households and societies 
Burden of medical expenditure on households and societies 
Burden of medical expenditure on households and societies 
Challenge 3: Burden of medical expenditure on households 
and societies 
US Institute of Medicine (2010): 
 “The growth rate of health care expenditures is unsustainable, with 
waste that diverts major resources from necessary care and other priorities 
..”. Sources of inefficiencies include: 
 Scientific uncertainty about effectiveness and cost, especially of newer test and 
treatments 
 Cultural predisposition to believe that more care is better 
 Innovations in health sector do not necessarily lead to increase in 
productivity as in other sectors – medical technologies major driver of 
health expenditure growth 
 
 
 
 
 
National Health Accounts 
http://apps.who.int/nha/database 
 
Global Health Observatory 
http://who.int/gho/database/en/ 
 
WHO  Global Health Expenditure Database: 
http://apps.who.int/nha/database/ViewData/Indicators/en 
 
 
 
 
 
Sources of data 
